---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-015861"
form_type: "8-K"
ticker: "AIM"
cik: "0000946644"
company_name: "AIM ImmunoTech Inc."
filed_at: "2025-06-20T23:59:59+00:00"
generated_at: "2026-05-19T02:25:12.119324+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# AIM ImmunoTech gets second NYSE American noncompliance notice for negative $3.9M equity

## Summary
- NYSE American warned AIM on June 17, 2025 for failing minimum stockholders' equity: negative $3.9M as of March 31, 2025.
- Company has losses in five most recent fiscal years; similar warning was issued on Dec 17, 2024.
- Compliance plan accepted Feb 26, 2025; AIM has until June 11, 2026 to regain compliance.
- AIM common stock recommenced trading June 17 under symbol 'AIM'; notice does not affect trading.

## SEC filing metadata
- accession: 0001641172-25-015861
- form_type: 8-K
- ticker: AIM
- cik: 0000946644
- company_name: AIM ImmunoTech Inc.
- filed_at: 2025-06-20T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946644/000164117225015861/0001641172-25-015861-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946644/000164117225015861/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-015861
- JSON: https://secwatch.observer/filing/0001641172-25-015861.json
- Plain text: https://secwatch.observer/filing/0001641172-25-015861.txt

## Key facts
- Listing & Compliance Notices
  AIM ImmunoTech Inc. received a nyse_american noncompliance notice notice regarding stockholders equity (rules 1003(a)(ii), 1003(a)(iii)).
  - Exchange: nyse american
  - Notice: noncompliance notice
  - Deficiency: stockholders equity
  - Rules: 1003(a)(ii), 1003(a)(iii)
  source text: June 17, 2025, AIM ImmunoTech Inc. (the “Company”) received a warning notification (the “Letter”) from the NYSE American LLC (the “NYSE American”) stating that the Company is not in compliance with the minimum stockholders’ equity requirements of Sections 1003(a)(ii) and 1003(a)(iii) of the NYSE American Company Guide (the “Company Guide”) requiring stockholders’ equity of $4.0 million or more if the Company has reported losses from continuing operations and/or net losses in three of the four most recent fiscal years and $6.0 million or more if the Company has reported losses from continuing o
  evidence_url: https://www.sec.gov/Archives/edgar/data/946644/000164117225015861/0001641172-25-015861-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.